Kamada KMDA
NASDAQ KMDA
$8.46 -0.23 (-2.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kamada (KMDA) Cash from Operations (2012 - 2026)

Updated

Kamada's Cash from Operations came in at $18.07 million for the quarter ended Jun 30, 2026, up 125.3% from $8.02 million a year earlier.

Analysis

Kamada (KMDA) Cash from Operations (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kamada reported Cash from Operations of $35.76 million, down 10.9% year-over-year; for the year ended Dec 31, 2025, it came in at $25.49 million, down 46.4% from the prior year.

  • Cash from Operations carries a five-year compound annual growth rate of 5.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Cash from Operations was $47.59 million in the year ended Dec 31, 2024, $4.32 million in the year ended Dec 31, 2023 (-84.9%), $28.59 million in the year ended Dec 31, 2022 and -$8.82 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Cash from Operations since the quarter ended Sep 30, 2024.
  • Year-over-year, Cash from Operations increased in two of the last five quarters, with growth averaging 14.5%.
  • The fastest year-over-year change in Cash from Operations over five years came in the quarter ended Jun 30, 2024 (growth of 668.0%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 83.3%).
  • Business Quant data shows KMDA's Cash from Operations at -$291,000 (quarter ended Mar 31, 2026), $7.57 million (quarter ended Dec 31, 2025) and $10.42 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn 18.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.07 Mn
Mar 31, 2026 -291,000.00
Dec 31, 2025 7.57 Mn
Sep 30, 2025 10.42 Mn
Jun 30, 2025 8.02 Mn
Mar 31, 2025 -513,000.00
Dec 31, 2024 10.40 Mn
Sep 30, 2024 22.21 Mn
Jun 30, 2024 13.96 Mn
Mar 31, 2024 1.02 Mn
Dec 31, 2023 6.11 Mn
Sep 30, 2023 921,000.00
Jun 30, 2023 1.82 Mn
Mar 31, 2023 -2.85 Mn
Dec 31, 2022 6.74 Mn
Sep 30, 2022 5.49 Mn
Jun 30, 2022 10.89 Mn
Mar 31, 2022 5.47 Mn
Dec 31, 2021 -4.97 Mn
Sep 30, 2021 -2.67 Mn
API Access

Kamada Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=KMDA&period=max&api_key=YOUR_API_KEY